Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07553572 · ClinicalTrials.gov registry record · NA
Remote Monitoring and Symptom Management Digital Application
A NA study, sponsored by Patrick C. Johnson, MD.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT07553572: Recruiting NA study, sponsored by Patrick C. Johnson, MD.
NCT07553572 is a NA study that is actively recruiting participants, run by Patrick C. Johnson, MD. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07553572, a NA study, is actively recruiting participants, sponsored by Patrick C. Johnson, MD.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to learn if an artificial intelligence phone application called ASSIST can help patients receiving cancer treatment. The main question\[s\] it aims to answer are: Is ASSIST feasible for patients (meaning can it be used by patients)? Is ASSIST acceptable to patients (meaning do patients like it)? Researchers will compare the ASSIST phone application to see how it compares to usual clinical care. Participants on the ASSIST arm will use the ASSIST phone application for 12 weeks, and participants in both groups will complete surveys.
Primary Outcome
We will deem the intervention feasible if recruitment rates achieve ≥ 60% of eligible patients
Interventions
- OTHER ASSIST phone application
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2026-04-14 |
| Est. Completion | 2027-03-31 |
| Phase | NA |
What NCT07553572 shows while recruiting
NCT07553572 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which ASSIST phone application is the first listed.
NCT07553572 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07553572 about?
NCT07553572 is a clinical study titled "Remote Monitoring and Symptom Management Digital Application". The goal of this clinical trial is to learn if an artificial intelligence phone application called ASSIST can help patients receiving cancer treatment. The main question\[s\] it aims to answer are: Is ASSIST feasible for patients (meaning can it be used by patients)? Is ASSIST acceptable to patien...
What is the current status of trial NCT07553572?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2026-04-14. Estimated completion is 2027-03-31.
What interventions are being tested in trial NCT07553572?
The interventions under investigation include: ASSIST phone application (OTHER).
Who is sponsoring clinical trial NCT07553572?
This trial is sponsored by Patrick C. Johnson, MD, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07553572's enrollment target sits among peer trials
60 1164th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI